•  Summary 
  •  
  •  Actions 
  •  
  •  Committee Votes 
  •  
  •  Floor Votes 
  •  
  •  Memo 
  •  
  •  Text 
  •  
  •  LFIN 
  •  
  •  Chamber Video/Transcript 

A07465 Summary:

BILL NOA07465
 
SAME ASSAME AS S04513
 
SPONSORKelles
 
COSPNSRRivera, Davila, Burdick, Simon, Sillitti, Epstein, Rosenthal L, Wallace, Lupardo, Gonzalez-Rojas, Paulin, Thiele, Bichotte Hermelyn, Steck, Stirpe, Smith, Reyes, Forrest, Lavine, Jean-Pierre, Jackson, Gunther, Hevesi, Dinowitz, Mamdani, Glick, Santabarbara
 
MLTSPNSR
 
Add Art 2-A Title IV 282 & 283, Pub Health L
 
Relates to preserving access to affordable drugs; provides that an agreement resolving or settling, on a final or interim basis, a patent infringement claim, in connection with the sale of a pharmaceutical product, shall be presumed to have anticompetitive effects if a nonreference drug filer receives anything of value from another company asserting patent infringement and if the nonreference drug filer agrees to limit or forego research, development, manufacturing, marketing, or sales of the nonreference drug filer's product for any period of time.
Go to top